Serum ascorbic acid and cardiovascular disease prevalence in U.S. adults

Epidemiology

Volumn 9, Issue 3, 1998, Pages 316-321

  Simon, Joel A ^a,b,c   Hudes, Esther S ^b   Browner, Warren S ^a,b  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Antioxidants; Ascorbic acid; Coronary disease; Peripheral vascular disease; Stroke

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; CORONARY RISK; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VASCULAR DISEASE; POPULATION RISK; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; STROKE; VITAMIN BLOOD LEVEL;

EID: 0031924683     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001648-199805000-00017     Document Type: Article

References (52)

1. Gey KF, Stähelin HB, Puska P, Evans A. Relationship of plasma level of vitamin C to mortality from ischemic heart disease. Ann NY Acad Sci 1987;498:110-120.
2. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary disease in men. N Engl J Med 1993;328:1450-1456.
3. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993;328:1444-1449.
4. Simon JA. Vitamin C and cardiovascular disease: a review. J Am Coll Nutr 1992;11:107-125.
5. Jacques PF, Sulsky SI, Sadowski JA, Phillips JCC, Rush D, Willett WC. Comparison of micronutrient intake measured by a dietary questionnaire and biochemical indicators of micronutrient status. Am J Clin Nutr 1993; 57:182-189.
6. Jacob RA, Skala JH, Omaye T. Biochemical indices of human vitamin C status. Am J Clin Nutr 1987;46:818-826.
7. National Center for Health Statistics. Plan and Operation of the Second National Health and Nutrition Examination Survey, 1976-1980. DHHS Pub. No. (PHS)81-1317. Hyattsville, MD: National Center for Health Statistics, 1981.
8. Gunter EW, Turner WE, Neese JW, Bayse DD. Laboratory procedures used by the Clinical Chemistry Division, Centers for Disease Control, for the Second National Health and Nutrition Examination Survey (HANES II) 1976-1980. Hyattsville, MD: National Center for Health Statistics, 1982.
9. National Center for Health Statistics - National Heart, Lung, and Blood Collaborative Group. Trends in serum cholesterol levels among U.S. adults aged 20 to 74: data from the National Health and Nutrition Examination Surveys, 1960 to 1980. JAMA 1987;257:937-942.
10. Lipid Research Clinics Program. Lipid and lipoprotein analysis. In: Manual of Laboratory Operations. vol. 1. DHEW Pub. No. (NIH)75-628. Bethesda, MD: National Institutes of Health, 1974.
11. Stata Corp Statistical Software. Release 5.0. College Station, TX: Stata Corp., 1996.
12. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology 1990;1:43-46.
13. Cleveland WS. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc 1979;74:829-836.
14. Hume R, Weyers E, Rowan T, Reid DS, Hillis WS. Leucocyte ascorbic acid levels after myocardial infarction. Br Heart J 1972;34:238-243.
15. Machtey I, Syrkis I, Fried M. Studies of blood ascorbic acid levels in acute myocardial infarction. Clin Chim Acta 1975;62:149-151.
16. Labadarios D, Brink PA, Weich HF, Visser L, Louw MEJ, Shephard GS, van Stuijvenberg ME. Plasma vitamin A, E, C and B6 levels in myocardial infarction. S Afr Med J 1987;71:561-563.
17. Hume R, Vallance BD, Muir MM. Ascorbate status and fibrinogen concentrations after cerebrovascular accident. J Clin Pathol 1982;35:195-199.
18. Sharpe PC, Mulholland C, Trinick T. Ascorbate and malondiadehyde in stroke patients. Ir J Med Sci 1994;163:488-491.
19. Barer D, Leibowitz R, Ebrahim S, Pengally D, Neale R. Vitamin C status and other nutritional indices in patients with stroke and other acute illnesses: a case-control study. J Clin Epidemiol 1989;42:625-631.
20. Gey KF, Stähelin HB, Eichholzer M. Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke: Basel Prospective Study. Clin Investigator 1993;71:3-6.
21. Enstrom JE, Kanim LE, Klein MA. Vitamin C intake and mortality among a sample of the United States population. Epidemiology 1992;3:194-202.
22. Knekt P, Reunanen A, Järvinen R, Seppänen R, Heliövaara M, Aromaa A. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol 1994;139:1180-1189.
23. Nyyssönen K, Parviainen MT, Salonen R, Korpela H, Tuomilehto J, Salonen JT. Vitamin C deficiency is associated with high risk of myocardial infarction in Eastern Finnish men (Abstract). Eur Heart J 1994;15(suppl): 168.
24. Gale CR, Martyn CN, Winter PD, Cooper C. Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people. BMJ 1995;310:1563-1566.
25. Frei B, Stocker R, England L, Ames BN. Ascorbate: the most effective antioxidant in human plasma. Adv Exp Med Biol 1990;264:155-163.
26. Jialal I, Vega GL, Grundy SM. Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoprotein. Atherosclerosis 1990;82: 185-191.
27. Harats D, Ben-Naim M, Dabach Y, Hollander G, Havivi E, Stein O, Stein Y. Effect of vitamin C and E supplementation on susceptibility of plasma lipoproteins to peroxidation induced by acute smoking. Atherosclerosis 1990;85:47-54.
28. Frei B. Ascorbic acid protects lipids in human plasma and low-density lipoprotein against oxidative damage. Am J Clin Nutr 1991;54:1113S-1118S.
29. Frei B, Forte TM, Ames BN, Cross CE. Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma: protective effects of ascorbic acid. Biochem J 1991; 277:133-138.
30. Retsky KL, Frei B. Vitamin C prevents metal ion-dependent initiation and propagation of lipid peroxidation in human low-density lipoprotein. Biochim Biophys Acta 1995;1257:279-287.
31. Gey KF. On the antioxidant hypothesis with regard to arteriosclerosis. Bibl Nutr Dieta 1986;37:53-91.
32. Steinberg D. Antioxidants and atherosclerosis: a current assessment. Circulation 1991;84:1420-1425.
33. Simon JA, Schreiber GB, Crawford PB, Frederick MM, Sabry ZI. Dietary vitamin C and serum lipids in black and white girls. Epidemiology 1993;4: 537-542.
34. Jacques PF, Sulsky SI, Perrone GA, Schaefer EJ. Ascorbic acid and plasma lipids. Epidemiology 1994;5:19-26.
35. 2 cholesterol. Am J Clin Nutr 1994;60:100-105.
36. Beetens JR, Herman AG. Vitamin C increases the formation of prostacyclin by aortic rings from various species and neutralizes the inhibitory effect of 15-hydroxy-arachidonic acid. Br J Pharmacol 1983;80:249-254.
37. 1 in washed human platelets and prostacyclin in rat aortic rings. Prostaglandins Leukot Med 1985;18:227-233.
38. Toivanen JL. Effects of selenium, vitamin E and vitamin C on human prostacyclin and thromboxane synthesis in vitro. Prostaglandins Leukot Med 1987;26:265-280.
39. Lefer AM. Prostacyclin, high density lipoproteins, and myocardial ischemia. Circulation 1990;81:2013-2015.
40. Lehr H-A, Frei B, Olofsson AM, Carew TE, Arfors K-E. Protection from oxidized LDL-induced leukocyte adhesion to microvascular and macrovascular endothelium in vivo by vitamin C but not vitamin E. Circulation 1995;91:1525-1532.
41. Knox EG. Ischemic-heart-disease mortality and dietary intake of calcium. Lancet 1973;1:1465-1467.
42. Ramirez J, Flowers NC. Leukocyte ascorbic acid and its relationship to coronary artery disease in man. Am J Clin Nutr 1980;33:2079-2087.
43. Gey KF, Moser UK, Jordan P, Stähelin HB, Eichholzer M, Lüdin E. Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: an epidemiologic update with special attention to carotene and vitamin C. Am J Clin Nutr 1993;57(suppl 5):787S-797S.
44. Riemersma RA, Wood DA, Macintyre CCA, Elton RA, Gey KF, Oliver MF. Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene. Lancet 1991;1:1-5.
45. Jha P, Flather M, Lonn E, Farouh M, Yusef S. The antioxidant vitamins and cardiovascular disease: a critical review of epidemiologic and clinical trial data. Ann Intern Med 1995;123:860-872.
46. Keli SO, Hertog MGL, Feskens EJM, Kromhout D. Dietary flavonoids, antioxidant vitamins, and incidence of stroke. Arch Intern Med 1996;154: 637-642.
47. Willis GC, Light AW, Gow WS. Serial arteriography in atherosclerosis. Can Med Assoc J 1954;71:562-568.
48. Katsouyanni K, Skalkidis Y, Petridou E, Polychronopoulou-Trichopoulou A, Willett W, Trichopoulos D. Diet and peripheral arterial occlusive disease: the role of poly-, mono-, and saturated fatty acids. Am J Epidemiol 1991; 133:24-31.
49. Donnan PT, Thomson M, Fowkes FGR, Prescott RJ, Housley E. Diet as a risk factor for peripheral arterial disease in the general population: the Edinburgh Artery Study. Am J Clin Nutr 1993;57:917-921.
50. Gey KF. Optimum plasma levels of antioxidant micronutrients. Bibl Nutr Dieta 1994;51:84-99.
51. Jacob RA, Pianalto FS, Agee RE. Cellular ascorbate depletion in healthy men. J Nutr 1992;122:1111-1118.
52. Marinelli MR, Beach KW, Glass M-JJ, Primozich JF, Strandness DEJ. Non-invasive testing vs clinical evaluation of arterial disease. JAMA 1979;241: 2031-303